Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026
Rhea-AI Summary
Balchem (NASDAQ: BCPC) will host a conference call on February 20, 2026 at 11:00 AM ET to review fourth quarter and full year 2025 results. Results and financial exhibits will be published prior to market open that day and posted on the company website.
The live webcast and replay will be available at the provided Q4 Events link; dial‑in details and Conference ID 4400943 are available for investors and analysts.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
BCPC is nearly flat at -0.17%, while key specialty chemical peers like SXT, CBT, ESI, SSL, and AXTA show broader declines between -0.15% and -6.36%, suggesting a more company-specific tone.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 07 | Earnings call notice | Neutral | -1.4% | Scheduled Q3 2025 results call and pre-open release timing. |
| Jul 17 | Earnings call notice | Neutral | +0.1% | Announced Q2 2025 call date, time, and access details. |
| Apr 11 | Earnings call notice | Neutral | +3.0% | Set Q1 2025 call schedule and release plan for results. |
| Feb 07 | Earnings call notice | Neutral | -2.5% | Announced Q4 and full-year 2024 call and release timing. |
| Oct 11 | Earnings call notice | Neutral | +1.2% | Outlined Q3 2024 results call logistics and replay window. |
Similar quarterly conference call announcements with earnings timing have historically produced small share moves, averaging about 0.09% around these notices.
Recent news flow mixes solid fundamentals with active investor outreach. The Q3 2025 earnings report on Oct 21, 2025 highlighted rising net sales, earnings, and reduced net debt. Since then, Balchem has announced industry conference appearances, an annual dividend of $0.96 per share with a 10.3% increase, and positive EU anti-dumping measures on choline chloride. Today’s Q4/FY25 call announcement continues the established pattern of pre-scheduled earnings communications to the market.
Historical Comparison
Over the last five ‘conferences,earnings’ notices, BCPC’s average move was only 0.09%, indicating that simple scheduling announcements have typically led to muted share-price reactions.
The company has consistently pre-announced quarterly earnings calls from 2024 through 2025, reinforcing a regular communications cadence as it reports successive quarterly and full-year financial results.
Market Pulse Summary
This announcement schedules Balchem’s Q4 and full-year 2025 results call for February 20, 2026, continuing its pattern of regular quarterly communications. Past ‘conferences,earnings’ notices have produced modest average moves of about 0.09%, suggesting the market typically waits for actual results. Investors may focus on how upcoming figures compare with strong Q3 2025 performance and ongoing balance-sheet improvements.
AI-generated analysis. Not financial advice.
MONTVALE, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 20, 2026, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call.
Fourth quarter and full year 2025 results will be published prior to the market opening on Friday, February 20, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call.
Institutional investors, analysts and other members of the financial community are invited to join the live call by dialing 800-715-9871 (toll free USA/Canada), +1-646-307-1963 (USA/International) or 647-932-3411 (Canada/Toronto), and referencing Conference ID 4400943, five minutes prior to the scheduled start time of the conference call. Investors and the public are invited to listen to the live webcast at https://events.q4inc.com/attendee/732063713. The conference call will be available for replay shortly after the conclusion of the call at https://events.q4inc.com/attendee/732063713 for one year.
About Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement, and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
| Contact: | Jacqueline Yarmolowicz, Executive Assistant Telephone: 845-326-5600 E-mail: jyarmolowicz@balchem.com |
FAQ
When will Balchem (BCPC) release fourth quarter and full year 2025 results?
What time is the Balchem (BCPC) earnings conference call on February 20, 2026?
How can investors join the Balchem (BCPC) live webcast for the February 20, 2026 call?
What dial‑in numbers and Conference ID are provided for Balchem (BCPC) February 20, 2026 call?
Will Balchem (BCPC) make the February 20, 2026 conference call replay available after the live event?
